Fracture Data Spurs Medtronic To Suspend Sales Of Fidelis ICD Lead

Medtronic's decision to halt worldwide distribution of its Sprint Fidelis defibrillator leads has attracted congressional scrutiny of the company's response to data showing the leads were vulnerable to fracture

More from Archive

More from Medtech Insight